Delayed Treatment with Systemic (S)-Roscovitine Provides Neuroprotection and Inhibits In Vivo CDK5 Activity Increase in Animal Stroke Models

Seliciclib in malignancies

(2009) Ibrahim T Aldoss et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Cell cycle inhibition attenuates microglial proliferation and production of IL-1β, MIP-1α, and NO after focal cerebral ischemia in the rat

(2009) Qiang Zhang et al.   GLIA

Pharmacologic Interventions for Stroke

(2009) Juan C. Chavez et al.   STROKE

Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations

(2009) Marc Fisher et al.   STROKE

Drug Therapies for Stroke and Traumatic Brain Injury Often Display U-Shaped Dose Responses: Occurrence, Mechanisms, and Clinical Implications

(2008) Edward J. Calabrese   CRITICAL REVIEWS IN TOXICOLOGY

Roscovitine Reduces Neuronal Loss, Glial Activation, and Neurologic Deficits after Brain Trauma

(2008) Genell D Hilton et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Neuroprotection for ischemic stroke: Past, present and future

(2008) Myron D. Ginsberg   NEUROPHARMACOLOGY

Age-dependent pharmacokinetics and effect of roscovitine on Cdk5 and Erk1/2 in the rat brain

(2008) H SALLAM et al.   PHARMACOLOGICAL RESEARCH